RAFAEL HOLDINGS, INC. Convertible Notes Payable
RAFAEL HOLDINGS, INC. (RFL) had Convertible Notes Payable of $1.90 million as of 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2023-06-13
- 2023-04-30: Convertible Notes Payable $1.90M.
| Period end | Convertible Notes Payable |
|---|---|
| 2023-04-30 | $1.90M 10-Q · filed 2023-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |